Hair Loss Clinical Trials

A Clinical Trial seeking patients for a research study for the treatment of Hair Disease.

An enriched plasma hair re-growth study for the treatment of male and female pattern hair loss. Are you interested in participating in a Hair Loss study to evaluate the thinning of hair using Platelet Rich Plasma for male and females with Androgenetic Alopecia (AGA)? Participants will receive treatment at no ...

Clinical research study in alopecia areata (AA). The Allegro 2b/3 research study aims to find out if an investigational medication can help treat people with AA who have lost 50% or more of the hair on their head.  

Are you or someone you care about living with Alopecia Areata? Alopecia Areata is an autoimmune disorder that causes patches of hair loss to occur and can even result in complete baldness. It’s a condition that can lead to significant emotional distress. While there is no FDA treatment approved for ...

Alopecia Areata is an autoimmune disease that commonly results in unpredictable, patchy hair loss that can affect the scalp and body. Alopecia can have major impacts on the quality of life of those diagnosed. If you or a loved one suffer from hair loss caused by Alopecia, a research study ...

Seeking adults with severe to very severe alopecia areata. Alopecia areata is an autoimmune disease that commonly results in unpredictable, patchy hair loss that can affect the scalp and body. Alopecia can have major impacts on the quality of life of those diagnosed. If you or a loved one suffer ...

The purpose of this study is to explore the safety, tolerability and activity of SXC-2023 when dosed for 6 weeks versus placebo in adult patients with moderate to severe Trichotillomania (TTM), also known as hair-pulling.  

This comparative study is a multi-center, prospective, blinded, randomized controlled clinical study where subjects act as their own control. The purpose of this study is to demonstrate that the ARTAS System is safe and effective for implanting follicular hair units. Patients will be followed for a nine months period of ...

Methods / trial design: Randomised, double-blind, vehicle-controlled multicentre trial in parallel groups. At screening (Visit 0), subjects will discontinue their previous treatment for alopecia areata, if any. Screening period will last up to 28 days. The 24-week treatment phase will include assessment Visits 1 to 3, which will take place ...

Hair loss is one of the most common complaints among all patients consulting a dermatologist and is usually associated with severe psychological disturbances, distress, and symptoms of depression. Most common forms of hair loss (alopecia) are caused by aberrant hair follicle cycling and changes in hair follicle morphology. Cells with ...